Culturally Aware AET Non-Initiation Intervention
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT05465408
- Status
- Completed
Conditions
- Breast Cancer
- Survivorship
- Treatment Adherence
- Treatment Compliance
- Treatment Refusal
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention — BEHAVIORALOne-to-One virtual (videoconference) behavioral intervention.
Study Details
The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
Key Dates
- Start date
- Jul 21, 2022
- Status verified
- Feb 2026
- Primary completion
- Nov 20, 2024
- Completion
- Nov 20, 2024
Study Design
- Enrollment
- 35 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation InterventionParticipants will have two (2), 60 minute, individual sessions with a nurse practitioner via videoconferencing (in person or via telephone) and complete three (3) questionnaires at the time of enrollment, 1-month post-baseline, and 3-months post-baseline.
Primary Outcome Measure
Program Feasibility [ Time Frame: Up to 3 months ]
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | - |
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | - |
| Dana-Farber Cancer Institute at St Elizabeth's Medical Center | Brighton | Massachusetts | 02135 | - |
| Emerson Hospital/MGH Cancer Center | Concord | Massachusetts | 01742 | - |
| Mass General at North Shore Cancer Center | Danvers | Massachusetts | 01923 | - |
| Dana-Farber Brigham Cancer Center - Foxborough | Foxborough | Massachusetts | 02035 | - |
| Dana-Farber Cancer Institute - Merrimack Valley | Methuen | Massachusetts | 01844 | - |
| Dana-Farber Brigham Cancer Center at Milford Regional Medical Center | Milford | Massachusetts | 01757 | - |
| Mass General at Newton Wellesley Hospital | Newton | Massachusetts | 02462 | - |
| Dana-Farber Brigham Cancer Center with South Shore Hospital | Weymouth | Massachusetts | 02190 | - |
| Dana-Farber/New Hampshire Onoclogy-Hematology | Londonderry | New Hampshire | 03053 | - |
Find similar trials in Boston, MA
By condition
By specialty
By research site
Dana-Farber Cancer Institute· Boston, MAMassachusetts General Hospital Cancer Center· Boston, MADana-Farber Cancer Institute at St Elizabeth's Medical Center· Brighton, MAEmerson Hospital/MGH Cancer Center· Concord, MAMass General at North Shore Cancer Center· Danvers, MADana-Farber Brigham Cancer Center - Foxborough· Foxborough, MA
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast CancerRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama